Survey About Diet in Chronic Inflammatory Rheumatic Diseases

French Survey on Patients' Practices, Knowledge and Beliefs About Diet in Chronic Inflammatory Rheumatic Diseases (Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis)

A French Survey on patients' practices, knowledge and beliefs about diet in chronic inflammatory rheumatic diseases (rheumatoid arthritis, psoriatic arthritis, spondylarthritis) Use of a questionnaire about what patients have heard concerning diet and rheumatism, what kind of diet they tried eventually and how it affected their health and disease

Study Overview

• Status: Active, not recruiting
• Conditions: Rheumatoid Arthritis; Psoriatic Arthritis; Spondylitis, Ankylosing; Feeding Behavior; Diet Habit; Spondyloarthritis; Inflammatory Rheumatism; Rheumatic Disease; Rheumatic Disorder
• Intervention / Treatment: Other: Questionnaire

• Study Type: Observational
• Enrollment (Actual): 203

Contacts and Locations

Study Locations

• France
  • Nouvelle Aquitaine
    • Poitiers, Nouvelle Aquitaine, France, 86000
      • CHU Poitiers

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Patients followed in the rheumatology department of the University Hospital of Poitiers (France) for chronic inflammatory rheumatism, going for consultation or hospitalisation for usual care

Description

Inclusion Criteria:

• Age ≥ 18 years
• Patient with chronic inflammatory rheumatism (rheumatoid arthritis, spondylarthritis, psoriatic arthritis) according to the diagnostic criteria commonly admitted
• Patient followed in the rheumatology department of the University Hospital of Poitiers (France)
• Free patient, without guardianship or tutelage or subordination
• Patient not opposing to participate in the study

Exclusion Criteria:

• Patient withdrawing consent
• Patient who does not meet criteria for chronic inflammatory disease (rheumatoid arthritis, spondylarthritis, psoriatic arthritis) according to the diagnostic criteria commonly admitted after examination of medical record

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort	Intervention / Treatment
Patients with chronic inflammatory rheumatic disease	Other: Questionnaire; A questionnaire about beliefs on food and diet in rheumatic diseases, and if a diet was tried what effect it had on health and rheumatism

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Prevalence (rate) of patients with chronic inflammatory rheumatism who have changed their dietary practices since being diagnosed.	To assess the prevalence of dietary changes in patients with chronic inflammatory rheumatism (rheumatoid arthritis, spondylarthritis and psoriatic arthritis) using a questionnaire	6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Rate of patients believing that diet affects their rheumatism	To describe the practices, knowledge and beliefs about diets of patients with chronic inflammatory rheumatism using a questionnaire	6 months
Rate of patients following each specific diet (gluten free, vegetarian, dairy products free, ...)	To describe the practices, knowledge and beliefs about diets of patients with chronic inflammatory rheumatism using a questionnaire	6 months
Comparison of the rates of patients believing that diet affects their rheumatism, between each subgroup of rheumatism	To compare dietary beliefs, knowledge and practices between different patient subgroups (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis) with their answers to the questionnaire	6 months
Comparison of the rates of patients following each specific diet (gluten free, vegetarian, dairy products free, ...) between each subgroup of rheumatism	To compare dietary beliefs, knowledge and practices between different patient subgroups (rheumatoid arthritis, spondyloarthritis, psoriatic arthritis) with their answers to the questionnaire	6 months
Comparison of the rates of patients who were able to stop a part of their treatment between the diet and non-diet groups	To compare drug management and disease activity between different dietary practices (with and without practice modification) with their answers to the questionnaire	6 months
Comparison of disease activity by the level of C reactive protein, DAS 28, ASDAS and BASDAI between the diet and non-diet groups	To compare drug management and disease activity between different dietary practices (with and without practice modification) with their answers to the questionnaire	6 months

Collaborators and Investigators

• Sponsor: Poitiers University Hospital

Study record dates

Study Major Dates

• Study Start (Actual): February 10, 2022
• Primary Completion (Actual): April 11, 2022
• Study Completion (Anticipated): September 30, 2022

Study Registration Dates

• First Submitted: February 5, 2022
• First Submitted That Met QC Criteria: March 8, 2022
• First Posted (Actual): March 16, 2022

Study Record Updates

• Last Update Posted (Actual): June 14, 2022
• Last Update Submitted That Met QC Criteria: June 11, 2022
• Last Verified: March 1, 2022

More Information

Terms related to this study

• Keywords: Questionnaire; Diet; Survey; Inflammatory Rheumatism
• Additional Relevant MeSH Terms: Skin Diseases; Infections; Immune System Diseases; Autoimmune Diseases; Joint Diseases; Musculoskeletal Diseases; Connective Tissue Diseases; Bacterial Infections; Bacterial Infections and Mycoses; Streptococcal Infections; Gram-Positive Bacterial Infections; Skin Diseases, Papulosquamous; Spinal Diseases; Bone Diseases; Spondylarthropathies; Spondylarthritis; Psoriasis; Bone Diseases, Infectious; Ankylosis; Arthritis; Arthritis, Rheumatoid; Arthritis, Psoriatic; Rheumatic Diseases; Collagen Diseases; Spondylitis; Spondylitis, Ankylosing; Rheumatic Fever
• Other Study ID Numbers: ALIRIC

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No